JAINA MEHTA: Open Payments
NPI 1841684487 · LUTZ, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$937 in 40 payments from 17 companies in 2025. Trend: 2023 $993 · 2024 $2,221 · 2025 $937
Food & beverage: $937
| Company | Payments | Amount |
|---|---|---|
| Kerecis Limited | 10 | $158 |
| Lilly USA, LLC | 5 | $128 |
| Galderma Laboratories, L.P. | 1 | $118 |
| Arcutis Biotherapeutics, Inc. | 4 | $93 |
| Novartis Pharmaceuticals Corporation | 2 | $56 |
| Amgen Inc. | 3 | $54 |
| ABBVIE INC. | 3 | $51 |
| LEO Pharma Inc. | 2 | $40 |
| GENZYME CORPORATION | 1 | $36 |
| Organon LLC | 2 | $36 |
Products named: Kerecis SurgiClose, EBGLYSS, NEMLUVIO, Zoryve, OTEZLA, SKYRIZI, DUPIXENT, VTAMA.
Industry payments across FL — which companies pay providers there.
